Preservation of acquired colistin resistance in Gram-negative bacteria

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 1, 2016, Pages 609-612

  Lee, Ji Young ^a   Choi, Myung Jin ^a   Choi, Hyeon Jin ^a   Ko, Kwan Soo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; MEMBRANE PROTEIN; PHOP PROTEIN, BACTERIA; PHOQ PROTEIN, BACTERIA; PMRA PROTEIN, BACTERIA; PMRB PROTEIN, BACTERIA; TRANSCRIPTION FACTOR;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM MUTANT; CONTROLLED STUDY; DRUG STABILITY; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; DRUG EFFECTS; GENE EXPRESSION; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; MUTATION RATE;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; COLISTIN; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; GENE EXPRESSION; KLEBSIELLA PNEUMONIAE; MEMBRANE PROTEINS; MICROBIAL SENSITIVITY TESTS; MUTATION RATE; PSEUDOMONAS AERUGINOSA; TRANSCRIPTION FACTORS;

EID: 84957871448     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01574-15     Document Type: Article

References (25)

1. Ko KS, Suh JY, Kwan KT, Jung SI, Park KH, Kang CI, Chung DR, Peck KR, Song JH. 2007. High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J Antimicrob Chemother 60:1163-1167. .
2. Lee JY, Song JH, Ko KS. 2011. Identification of nonclonal Pseudomonas aeruginosa isolates with reduced colistin susceptibility in Korea. Microb Drug Resist 17:299-304. http://dx.doi.org/10.1089/mdr.2010.0145.
3. Suh JY, Son JS, Chung DR, Peck KR, Ko KS, Song JH. 2010. Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea. Antimicrob Agents Chemother 54:560-562. http://dx.doi.org/10.1128/AAC.00762-09.
4. Olaitan AO, Morand S, Rolain JM. 2014. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol 5:643. http://dx.doi.org/10.3389/fmicb.2014.00643.
5. Skiada A, Markogiannakis A, Plachouras D, Daikos GL. 2011. Adaptive resistance to cationic compounds in Pseudomonas aeruginosa. Int J Antimicrob Agents 37:187-193. http://dx.doi.org/10.1016/j.ijantimicag.2010.11.019.
6. Bartual SG, Seifert H, Hippler C, Luzon MA, Whisplinghoff H, Rodriguez-Valera F. 2005. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol 43:4382-4390. http://dx.doi.org/10.1128/JCM.43.9.4382-4390.2005.
7. Curran B, Jonas D, Grundmann H, Pitt T, Dowson CG. 2004. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol 42:5644-5649. http://dx.doi.org/10.1128/JCM.42.12.5644-5649.2004.
8. Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. 2005. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 43:4178-4182. http://dx.doi.org/10.1128/JCM.43.8.4178-4182.2005.
9. Lau SH, Reddy S, Cheesbrough J, Bolton FJ, Willshaw G, Cheasty T, Fox AJ, Upton M. 2008. Major uropathogenic Escherichia coli strain isolated in the northwest of England by multilocus sequence typing. J Clin Microbiol 46:1076-1080. http://dx.doi.org/10.1128/JCM.02065-07.
10. Clinical and Laboratory Standards Institute. 2013. Performance standards for antimicrobial susceptibility testing: twenty-first informational supplement M100-S23. CLSI, Wayne, PA.
11. European Committee on Antimicrobial Susceptibility Testing. 2015. Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0. http://www.eucast.org/.
12. Park YK, Choi JY, Shin D, Ko KS. 2011. Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii. Int J Antimicrob Agents 37:525-530. http://dx.doi.org/10.1016/j.ijantimicag.2011.02.008.
13. Yau W, Owen RJ, Poudyal A, Bell JM, Turnidge JD, Yu HH, Nation RL, Li J. 2009. Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme. J Infect 58:138-144. http://dx.doi.org/10.1016/j.jinf.2008.11.002.
14. El-Halfawy OM, Valvano MA. 2015. Antimicrobial heteroresistance: an emerging field in need of clarity. Clin Microbiol Rev 28:191-207. http://dx.doi.org/10.1128/CMR.00058-14.
15. Choi MJ, Ko KS. 17 August 2015. Loss of hypermucoviscosity and increased fitness cost in colistin-resistant Klebsiella pneumoniae sequence type 23 strains. Antimicrob Agents Chemother 59:6763-6773. http://dx.doi.org/10.1128/AAC.00952-15.
16. Lee JY, Ko KS. 2014. Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolates. Diagn Microbiol Infect Dis 78:271-276. http://dx.doi.org/10.1016/j.diagmicrobio.2013.11.027.
17. Lee JY, Lim MH, Heo ST, Ko KS. 2012. Repeated isolation of Pseudomonas aeruginosa isolates resistant to both polymyxins and carbapenems from 1 patient. Diagn Microbiol Infect Dis 72:267-271. http://dx.doi.org/10.1016/j.diagmicrobio.2011.11.014.
18. Snitkin ES, Zelazny AM, Gupta J, NISC Comparative Sequencing Program, Palmore TN, Murray PR, Segre JA. 2013. Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatment. Genome Res 23:1155-1162. http://dx.doi.org/10.1101/gr.154328.112.
19. Choi MJ, Ko KS. 2014. Mutant prevention concentrations of colistin for Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae clinical isolates. J Antimicrob Chemother 69:275-277. http://dx.doi.org/10.1093/jac/dkt315.
20. Cannatelli A, Giani T, D'Andrea MM, Di Pilato V, Arena F, Conte V, Tryfinopoulou K, Vatopoulos A, Rossolini GM, COLGRIT Study Group. 2014. MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin. Antimicrob Agents Chemother 58:5696-5703. http://dx.doi.org/10.1128/AAC.03110-14.
21. Olaitan AO, Diene SM, Kempf M, Berrazeg M, Bakour S, Gupta SK, Thongmalayvong B, Akkhavong K, Somphavong S, Paboriboune P, Chaisiri K, Komalamisra C, Adelowo OO, Fagade OE, Banjo OA, Oke AJ, Adler A, Assous MV, Morand S, Raoult D, Rolain JM. 2014. Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study. Int J Antimicrob Agents 44:500-507. http://dx.doi.org/10.1016/j.ijantimicag.2014.07.020.
22. Poirel L, Jayol A, Bontron S, Villegas MV, Ozdamar M, Türkoglu S, Nordmann P. 2015. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J Antimicrob Chemother 70:75-80. http://dx.doi.org/10.1093/jac/dku323.
23. Wright MS, Jones MB, Marshall SH, Rudin SD, van Duln D, Kaye K, Jacobs MR, Bonomo RA, Adams MD. 2015. Genomic and transcriptomic analyses of colistin-resistant clinical isolates of Klebsiella pneumoniae reveal multiple pathways of resistance. Antimicrob Agents Chemother 59:536-543. http://dx.doi.org/10.1128/AAC.04037-14.
24. Lopez-Rojas R, Jimenez-Mejias ME, Lepe JA, Pachon J. 2011. Acinetobacter baumannii resistant to colistin alters its antibiotic resistance profile: a case report from Spain. J Infect Dis 204:1147-1148. http://dx.doi.org/10.1093/infdis/jir476.
25. Pournaras S, Poulou A, Dafopoulou K, Chabane YN, Kristo I, Makris D, Hardouin J, Cosette P, Tsakris A, Dé E. 2014. Growth retardation, reduced invasiveness, and impaired colistin-mediated cell death associated with colistin resistance development in Acinetobacter baumannii. Antimicrob Agents Chemother 58:828-832. http://dx.doi.org/10.1128/AAC.01439-13.